Inactivation of the candidate tumor suppressor par-4 in endometrial cancer
- PMID: 17332319
- DOI: 10.1158/0008-5472.CAN-06-2687
Inactivation of the candidate tumor suppressor par-4 in endometrial cancer
Abstract
Recently, it has been shown that mice deficient in the proapoptotic protein prostate apoptosis response 4 (Par-4) are specifically prone to develop endometrial carcinomas. Based on this, we have examined here the possible role of Par-4 as a tumor suppressor gene in human endometrial cancer. Using cDNA arrays, quantitative reverse transcription-PCR, and immunohistochemistry, we detected Par-4 down-regulation in approximately 40% of endometrial carcinomas. This alteration was not associated with phosphatase and tensin homologue (PTEN), K-RAS, or beta-catenin mutations, but was more frequent among tumors showing microsatellite instability (MSI) or among tumors that were estrogen receptor positive. Mutational analysis of the complete coding sequence of Par-4 in endometrial cancer cell lines (n = 6) and carcinomas (n = 69) detected a mutation in a single carcinoma, which was localized in exon 3 [Arg (CGA) 189 (TGA) Stop]. Interestingly, Par-4 promoter hypermethylation was detected in 32% of the tumors in association with low levels of Par-4 protein and was more common in MSI-positive carcinomas. Par-4 promoter hypermethylation and silencing was also detected in endometrial cancer cell lines SKUT1B and AN3CA, and reexpression was achieved by treatment with the demethylating agent 5'-aza-2'-deoxycytidine. Together, these data show that Par-4 is a relevant tumor suppressor gene in human endometrial carcinogenesis.
Similar articles
-
BAX somatic frameshift mutations in endometrioid adenocarcinomas of the endometrium: evidence for a tumor progression role in endometrial carcinomas with microsatellite instability.Lab Invest. 1998 Nov;78(11):1439-44. Lab Invest. 1998. PMID: 9840618
-
Methylation of adenomatous polyposis coli in endometrial cancer occurs more frequently in tumors with microsatellite instability phenotype.Cancer Res. 2002 Jul 1;62(13):3663-6. Cancer Res. 2002. PMID: 12097272
-
Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators.Am J Surg Pathol. 2007 Jun;31(6):846-53. doi: 10.1097/01.pas.0000213423.30880.ac. Am J Surg Pathol. 2007. PMID: 17527071
-
Theories of endometrial carcinogenesis: a multidisciplinary approach.Mod Pathol. 2000 Mar;13(3):295-308. doi: 10.1038/modpathol.3880051. Mod Pathol. 2000. PMID: 10757340 Review.
-
Molecular and pathologic aspects of endometrial carcinogenesis.J Clin Oncol. 2006 Oct 10;24(29):4783-91. doi: 10.1200/JCO.2006.06.7173. J Clin Oncol. 2006. PMID: 17028294 Review.
Cited by
-
Crizotinib induces Par-4 secretion from normal cells and GRP78 expression on the cancer cell surface for selective tumor growth inhibition.Am J Cancer Res. 2023 Mar 15;13(3):976-991. eCollection 2023. Am J Cancer Res. 2023. PMID: 37034206 Free PMC article.
-
Tumor Suppressor Par-4 Regulates Complement Factor C3 and Obesity.Front Oncol. 2022 Mar 29;12:860446. doi: 10.3389/fonc.2022.860446. eCollection 2022. Front Oncol. 2022. PMID: 35425699 Free PMC article.
-
Prostate apoptosis response-4 and tumor suppression: it's not just about apoptosis anymore.Cell Death Dis. 2021 Jan 7;12(1):47. doi: 10.1038/s41419-020-03292-1. Cell Death Dis. 2021. PMID: 33414404 Free PMC article. Review.
-
Validation of target proteins of down-regulated miR-221-5p in HeLa cells treated with Polyalthia longifolia leaf extract using label-free quantitative proteomics approaches.3 Biotech. 2020 Sep;10(9):399. doi: 10.1007/s13205-020-02396-x. Epub 2020 Aug 19. 3 Biotech. 2020. PMID: 32850286 Free PMC article.
-
Development of a novel prostate apoptosis response-4 (Par-4) protein entity with an extended duration of action for therapeutic treatment of cancer.Protein Eng Des Sel. 2019 Dec 13;32(3):159-166. doi: 10.1093/protein/gzz034. Protein Eng Des Sel. 2019. PMID: 31711233 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous